More articles from Commentary

You have access
Process Parametric Release—The Canadian Regulatory View
Francois Chevalier

PDA Journal of Pharmaceutical Science and Technology September 1985, 39 (5) 190-193;
You have access
An FDA Update on GMP’s For Aseptic Processing
Edmund M. Fry

PDA Journal of Pharmaceutical Science and Technology July 1985, 39 (4) 154-157;
You have access
Compliance Issues in 1985
Daniel L. Michels

PDA Journal of Pharmaceutical Science and Technology July 1985, 39 (4) 158-160;
You have access
Control Aspects of Aseptically Produced Products
Henry L. Avallone

PDA Journal of Pharmaceutical Science and Technology March 1985, 39 (2) 75-79;
You have access
The USP Monographs on Biological Indicators
Murray S. Cooper

PDA Journal of Pharmaceutical Science and Technology March 1985, 39 (2) 80-83;
You have access
PDA Particulate Matter Panel Discussion—An Industry Perspective
Henry F. Hammer

PDA Journal of Pharmaceutical Science and Technology September 1984, 38 (5) 170-172;
You have access
Retrospective View of the Interfacial Relationship of the Pharmaceutical Industry With the Food and Drug Administration and the United States Pharmacopeia
Henry F. Hammer

PDA Journal of Pharmaceutical Science and Technology July 1984, 38 (4) 159-163;
You have access
The Advisory Role of FDA District Offices in the Planning of a New Parenteral Facility
Ronald F. Tetzlaff

PDA Journal of Pharmaceutical Science and Technology May 1984, 38 (3) 94-97;
You have access
Successful Selection of Professional People
James F. Snyder

PDA Journal of Pharmaceutical Science and Technology March 1984, 38 (2) 64-67;
You have access
Perspectives on Alternative Methods of Toxicological Testing
Sharon J. Northup

PDA Journal of Pharmaceutical Science and Technology November 1983, 37 (6) 225-226;

Main menu

User menu

Search

More articles from Commentary

Pages

Readers

Author/Reviewer Information

Parenteral Drug Association, Inc.